AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21641515
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) treatment (Glucosidorum Tripterygll Totorum tablets and Yishen Juanbi tablets)
Trial: 21641515
Drug: Western Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western Medicine (WM) treatment (diclofenec, methotrexate and sulfasalazine)
Trial: 21641515
Drug: Western Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western Medicine (WM) treatment
Trial: 18359425
Drug: Targeted antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted antibiotic therapy (TT)
Trial: 18359425
Drug: No targeted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No targeted therapy (NoTT)
Trial: 16509530
Drug: Daily comprehensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily comprehensive muscle training programme (4-10 minutes daily)
Trial: 11009231
Drug: Mexiletine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexiletine (maximum dose of 1,350 mg/d)
Trial: 9112363
Drug: Isradipine (0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (0.005 mg/kg)
Trial: 8495257
Drug: Pyritinol (PY)
RxNorm normalized name: pyritinol
DrugBank: Pyritinol (DB13084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyritinol (PY) 600 mg/day for 1 year
Trial: 8495257
Drug: Auranofin (AU)
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin (AU) 6 mg/day for 1 year
Trial: 3632393
Drug: High-dose prednisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisone therapy (1.5 mg/kg daily, max 80 mg for six months)
Trial: 25634801
Drug: WBRT +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WBRT + sodium nitrite (267 µg/kg/h for 2 hours before each radiation fraction)
Trial: 21211975
Drug: De Marco
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De Marco Formula (DMF) combined with conventional therapy (0, 15 ml/kg day i.m. for 10 days, then twice a week until healing or 52 days)
Trial: 18264992
Drug: Test procedure
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test procedure for treatment effects among compliers
Trial: 14513439
Drug: 500 cGy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 cGy radiation treatment (group A)
Trial: 14513439
Drug: 1,000 cGy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 cGy radiation treatment (group B)
Trial: 10739327
Drug: Olanzapine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5 to 20 mg/day)
Trial: 27884147
Drug: Standard cardiac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cardiac rehabilitation programme + four osteopathic treatments (OT) at weeks 4, 5, 8, and 12 after surgery.
Trial: 18071011
Drug: Inhaled ciclesonide
RxNorm normalized name: ciclesonide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ciclesonide 160 microg daily for 3 weeks
Trial: 18071011
Drug: Inhaled ciclesonide
RxNorm normalized name: ciclesonide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ciclesonide 320 microg daily for 3 weeks
Trial: 18071011
Drug: Inhaled ciclesonide
RxNorm normalized name: ciclesonide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ciclesonide 40 microg daily for 3 weeks
Trial: 18071011
Drug: Inhaled ciclesonide
RxNorm normalized name: ciclesonide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled ciclesonide 80 microg daily for 3 weeks
Trial: 14697160
Drug: piperacillin/tazobactam (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: piperacillin/tazobactam (4 g/8 h iv)
Trial: 14697160
Drug: ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ceftriaxone (2 g/24 h iv) plus ornidazole (1 g/24 h iv)
Trial: 10579472
Drug: Quinine hydrochloride
RxNorm normalized name: quinine hydrochloride
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine hydrochloride (500 mg) plus ketoconazole (100 mg twice daily for 3 days)
Trial: 10579472
Drug: Quinine hydrochloride
RxNorm normalized name: quinine hydrochloride
DrugBank: Quinine (DB00468)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quinine hydrochloride (500 mg) plus fluvoxamine (25 mg twice daily for 2 days)
Trial: 2047064
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (25-mg tablets orally every 8 hours for 72 hours)
Trial: 27338807
Drug: Lemborexant (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemborexant (2.5 to 75 mg) administered for 14 consecutive nights
Trial: 27338807
Drug: Lemborexant (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lemborexant (2.5, 10, or 25 mg) administered for 14 consecutive nights
Trial: 26637091
Drug: Baroreflex sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baroreflex sensitivity test (BRS) in supine position (L-BRS)
Trial: 20110022
Drug: Atorvastatin/Fenofibrate FDC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin/Fenofibrate FDC (40 mg/100 mg)
Trial: 20110022
Drug: Fenofibrate 145
RxNorm normalized name: fenofibrate 145 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 145 mg
Trial: 15623686
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg CAB once daily
Trial: 15623686
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg CAB once daily
Trial: 15623686
Drug: 2.0 mg
RxNorm normalized name: LORAZEPAM 2.0 mg in 1 mL INTRAVENOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 mg CAB once daily
Trial: 15623686
Drug: CAB therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAB therapy (mean dose of 2.2 mg per day over 1 year)
Trial: 11242379
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment with distraction and fusion using Harrington rods
Trial: 9260078
Drug: Cola at
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cola at 33 mg/serving
Trial: 9260078
Drug: Coffee at
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee at 33 mg/serving
Trial: 9260078
Drug: Cola at
RxNorm normalized name: cola extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cola at 100 mg/serving
Trial: 9260078
Drug: Coffee at
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coffee at 100 mg/serving
Trial: 8501457
Drug: Buprenorphine 6
RxNorm normalized name: buprenorphine 6.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 6 mg
Trial: 8501457
Drug: Methadone 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 35 mg
Trial: 8501457
Drug: Methadone 65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone 65 mg
Trial: 10799369
Drug: EPA (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (4 g daily)
Trial: 24355229
Drug: Inhaled crenotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled crenotherapy with salso-sulphide water
Trial: 18003666
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of folic acid (2.5 mg), vitamin B6 (50 mg), and vitamin B12 (1 mg) daily for 5 years
Trial: 18003666
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of folic acid, vitamin B6, and vitamin B12
Trial: 15910349
Drug: S-ketamine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-ketamine (0.2 mg.kg‐1 bolus followed by 5 microg.kg‐1.min‐1 infusion)
Trial: 12909221
Drug: GEM CCRT
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GEM CCRT (600 mg/m(2)/wk for 6 weeks)
Trial: 12909221
Drug: 5-FU CCRT
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU CCRT (500 mg/m(2)/d for 3 days repeated every 2 weeks for 6 weeks)
Trial: 6666215
Drug: Intravenous isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous isosorbide dinitrate (50‐200 micrograms/kg/h)
Trial: 6666215
Drug: Intravenous frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous frusemide (1 mg/kg)
Trial: 31931250
Drug: Dexmedetomidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1 μg/kg slow pumping dose, maintained at 0.3 μg/kg·h intraoperatively)
Trial: 31931250
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion (same amount as dexmedetomidine, same infusion method)
Trial: 29410607
Drug: Music intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Music intervention (MTSZ) group, received a 1-month music intervention series combined with antipsychotic drugs
Trial: 29410607
Drug: No-music intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-music intervention (UMTSZ) group, treated solely with antipsychotic drugs
Trial: 24302681
Drug: Pregnenolone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregnenolone (400 mg)
Trial: 21081550
Drug: varespladib methyl
RxNorm normalized name: Varespladib methyl
DrugBank: Varespladib methyl (DB05737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: varespladib methyl 500 mg once daily
Trial: 21081550
Drug: varespladib methyl
RxNorm normalized name: Varespladib methyl
DrugBank: Varespladib methyl (DB05737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: varespladib methyl 250 mg once daily
Trial: 16189179
Drug: l-arginine/GHRP-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-arginine/GHRP-2
Trial: 16189179
Drug: l-arginine/GHRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-arginine/GHRH
Trial: 12574185
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol (2 mg/d)
Trial: 12574185
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (patch delivering 50 microg/d)
Trial: 8889112
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (group 1, n = 27)
Trial: 8889112
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (group 2, n = 34)
Trial: 6339923
Drug: Acyclovir (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (200 mg per dose) five times daily for 10 days
Trial: 30503296
Drug: Helical IMRT-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helical IMRT-based stereotactic body radiotherapy (SBRT) at dose levels 3-4 (42-60 Gy)
Trial: 22260307
Drug: Anterior suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anterior suspension and posterior reconstruction during RALP (group B)
Trial: 19499849
Drug: Alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-lipoic acid (ALA) 600 mg/die and gamma-linolenic acid (GLA) 360 mg/die
Trial: 19499849
Drug: Multivitamin B
RxNorm normalized name: Avobenzone 2.5 mL in 125 mL / Octinoxate 9.4 mL in 125 mL / Octisalate 6.25 mL in 125 mL / Oxybenzone 3.75 mL in 125 mL TOPICAL LOTION [Multivitamin Bodyblock SPF 20]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin B preparation (Vit B6 150 mg, Vit B1 100 mg, Vit B12 500 microg daily)
Trial: 19499849
Drug: Multivitamin B
RxNorm normalized name: Avobenzone 2.5 mL in 125 mL / Octinoxate 9.4 mL in 125 mL / Octisalate 6.25 mL in 125 mL / Oxybenzone 3.75 mL in 125 mL TOPICAL LOTION [Multivitamin Bodyblock SPF 20]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin B preparation
Trial: 24890138
Drug: Rosiglitazone 8
RxNorm normalized name: rosiglitazone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 8 mg
Trial: 16366763
Drug: Cocaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (100 mg)
Trial: 11519636
Drug: Cocaine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (200 mg)
Trial: 16366763
Drug: Cocaine (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine (0 mg)
Trial: 12169865
Drug: L-threo-3,4-dihydroxyphenylserine (L-DOPS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 200 mg or 400 mg
Trial: 8641325
Drug: Buffered sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered sublingual captopril (pH 7)
Trial: 8641325
Drug: Unbuffered sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unbuffered sublingual captopril
Trial: 8641325
Drug: Buffered and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffered and unbuffered sublingual captopril
Trial: 25840296
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia associated with cryoanalgesia
Trial: 21739693
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine group (Simo Decoction oral solution, three times daily for 10 days)
Trial: 10434237
Drug: Azithromycin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (1200 mg)
Trial: 25709054
Drug: Daily Undulating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Undulating Progression (DUP)
Trial: 23588309
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg rifampin once daily for 7 days
Trial: 16841662
Drug: Pricking collateral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pricking collateral blood therapy (PCBT) combined with massage therapy
Trial: 19148112
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy alone
Trial: 12434720
Drug: Intravenous argatroban
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous argatroban infused at a rate of 1.25 micrograms/kg/min for 100 hours
Trial: 12434720
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral 7.5-mg dose of warfarin
Trial: 12434720
Drug: Argatroban administered
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban administered alone
Trial: 12434720
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of argatroban and warfarin
Trial: 12434720
Drug: Argatroban administered
RxNorm normalized name: Argatroban
DrugBank: Argatroban (DB00278)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Argatroban administered alone or with warfarin
Trial: 8560532
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg over 3 days)
Trial: 9707362
Drug: Quinine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (10 mg/kg per 8 hourly for 5 days)
Trial: 368538
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of prazosin
Trial: 368538
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of hydrallazine
Trial: 23010344
Drug: Tanezumab (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab (20 mg, single intravenous dose)
Trial: 9830646
Drug: Gel containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel containing silicon dioxide, aloe vera, and allantoin
Trial: 9830646
Drug: Control gel
RxNorm normalized name: SALICYLIC ACID 20 mg in 1 mL TOPICAL GEL [Walgreens Acne Control Gel]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control gel with silicon dioxide
Trial: 9830646
Drug: Gel with
RxNorm normalized name: GEL WITH PUMP (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel with all 3 active substances
Trial: 30928954
Drug: Luseogliflozin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luseogliflozin 2.5 mg once daily
Trial: 19332985
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose (based on the calculated total iron deficit divided into 2 ampoule infusions intravenously 3 times a week, beginning 3 weeks before surgery)
Trial: 19332985
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron protein succinylate (80 mg/day)
Trial: 19332985
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron protein succinylate
Trial: 16785154
Drug: CC/hMG/cetrorelix protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC/hMG/cetrorelix protocol
Trial: 15472846
Drug: Guideline implementation
RxNorm normalized name: LARYNGEAL GUIDEWIRE,PROVOX #7215
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline implementation for the treatment of CAP
Trial: 11041314
Drug: Acute hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Acute hydrocortisone (100 mg, orally 11 h before)
Trial: 11041314
Drug: Chronic hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Chronic hydrocortisone (20 mg twice a day for 1 week)
Trial: 9309369
Drug: Ceftibuten 400
RxNorm normalized name: ceftibuten 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftibuten 400 mg o.d.
Trial: 9309369
Drug: Amoxicillin/clavulanate (AMX/CA)
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (AMX/CA) 500 mg/125 mg t.i.d.
Trial: 2939862
Drug: Atracurium 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium 0.3 mg kg‐1
Trial: 2939862
Drug: Suxamethonium 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suxamethonium 1.6 mg kg‐1 plus infusion
Trial: 31285357
Drug: Tight control
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight control (TC) strategy with adalimumab (40 mg sc)
Trial: 20667854
Drug: Epidural cortical
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural cortical stimulation during intensive speech-language therapy
Trial: 20667854
Drug: Intensive speech-language
RxNorm normalized name: California intense cedar pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive speech-language therapy without epidural stimulation (Control)
Trial: 10027447
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (n = 31) with targeted oxygen delivery index (DO2I) value of > 600 mL/min/m2
Trial: 10027447
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n = 32) with conventional therapy and normal targeted oxygen delivery
Trial: 10027447
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (n = 31)
Trial: 1675225
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (bolus injection)
Trial: 6185041
Drug: Quinine 10
RxNorm normalized name: quinine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine 10 mg base per body weight every eight hours for 14 days (Group I)
Trial: 6185041
Drug: Quinine adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine adjusted to body surface area based on an adult dose of 500 mg base eight hourly for 14 days (Group II)
Trial: 15323576
Drug: Subcutaneous apomorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous apomorphine 4mg
Trial: 15323576
Drug: Intermittent subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent subcutaneous apomorphine injections
Trial: 15323576
Drug: Continuous subcutaneous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous subcutaneous apomorphine infusions
Trial: 11731749
Drug: Mannitol 0.5
RxNorm normalized name: MANNITOL 0.54%/SORBITOL 2.7% IRRG SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol 0.5 g.kg‐1 as bolus at the start of skin incision, and postoperatively 0.5 g.kg‐1 daily three times a day for 3 days (72 hrs)
Trial: 11731749
Drug: Mannitol 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol 0.25 g.kg‐1 as bolus at the start of skin incision plus 3% HTS, 20 ml.h‐1 intraoperatively and mannitol 0.25 g.kg‐1 daily three times a day for 3 days plus HTS in the concentration of 3% in the first day and 2% and 1% the second and the third day after surgery
Trial: 11731749
Drug: 3% HTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% HTS 3.5 ml kg‐1 as bolus at the start of skin incision plus 3% HTS, 20 ml hr‐1 intraoperatively and 3% HTS, 20 ml h‐1 on the first day and 2% and 1% the second and the third day after surgery